Cooperative activation of cardiac transcription through myocardin bridging of paired MEF2 sites

Enhancers frequently contain multiple binding sites for the same transcription factor. These homotypic binding sites often exhibit synergy, whereby the transcriptional output from two or more binding sites is greater than the sum of the contributions of the individual binding sites alone. Although this phenomenon is frequently observed, the mechanistic basis for homotypic binding site synergy is poorly understood. Here, we identify a bona fide cardiac-specific Prkaa2 enhancer that is synergistically activated by homotypic MEF2 binding sites. We show that two MEF2 sites in the enhancer function cooperatively due to bridging of the MEF2C-bound sites by the SAP domain-containing co-activator protein myocardin, and we show that paired sites buffer the enhancer from integration site-dependent effects on transcription in vivo. Paired MEF2 sites are prevalent in cardiac enhancers, suggesting that this might be a common mechanism underlying synergy in the control of cardiac gene expression in vivo. Summary: In mice, bridging of paired MEF2C-bound MEF2 sites in a cardiac enhancer of the Prkaa2 gene by the transcriptional co-activator myocardin promotes cooperativity between the two homotypic elements.

[1]  J. Miano Myocardin in biology and disease , 2014, Journal of biomedical research.

[2]  Feng Zhang,et al.  Genome engineering using CRISPR-Cas9 system. , 2015, Methods in molecular biology.

[3]  B. Black,et al.  An arterial-specific enhancer of the human endothelin converting enzyme 1 (ECE1) gene is synergistically activated by Sox17, FoxC2, and Etv2. , 2014, Developmental biology.

[4]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[5]  Sarah C R Elgin,et al.  Position-effect variegation, heterochromatin formation, and gene silencing in Drosophila. , 2013, Cold Spring Harbor perspectives in biology.

[6]  Rudolf Jaenisch,et al.  One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering , 2013, Cell.

[7]  Alexander R. Pico,et al.  Dynamic and Coordinated Epigenetic Regulation of Developmental Transitions in the Cardiac Lineage , 2012, Cell.

[8]  R. Young,et al.  Histone H3K27ac separates active from poised enhancers and predicts developmental state , 2010, Proceedings of the National Academy of Sciences.

[9]  R. Cripps,et al.  Myocyte Enhancer Factor 2 Transcription Factors in Heart Development and Disease , 2010 .

[10]  E. Olson,et al.  MEF2: a central regulator of diverse developmental programs , 2007, Development.

[11]  M. Parmacek,et al.  Myocardin-related transcription factors: critical coactivators regulating cardiovascular development and adaptation. , 2007, Circulation research.

[12]  E. Creemers,et al.  Coactivation of MEF2 by the SAP domain proteins myocardin and MASTR. , 2006, Molecular cell.

[13]  E. Creemers,et al.  The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. , 2006, Genes & development.

[14]  B. Black,et al.  Gata4 expression in lateral mesoderm is downstream of BMP4 and is activated directly by Forkhead and GATA transcription factors through a distal enhancer element , 2005, Development.

[15]  B. Black,et al.  Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer. , 2004, Developmental biology.

[16]  Da-Zhi Wang,et al.  Control of smooth muscle development by the myocardin family of transcriptional coactivators. , 2004, Current opinion in genetics & development.

[17]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[18]  E. Dodou,et al.  HRC Is a Direct Transcriptional Target of MEF2 during Cardiac, Skeletal, and Arterial Smooth Muscle Development In Vivo , 2004, Molecular and Cellular Biology.

[19]  E. Dodou,et al.  mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo , 2003, Mechanisms of Development.

[20]  Da-Zhi Wang,et al.  The serum response factor coactivator myocardin is required for vascular smooth muscle development , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Da-Zhi Wang,et al.  Myocardin is a master regulator of smooth muscle gene expression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Kitsis,et al.  Microarray analysis of global changes in gene expression during cardiac myocyte differentiation. , 2002, Physiological genomics.

[23]  B. Black,et al.  Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. , 1998, Annual review of cell and developmental biology.

[24]  C. Bucana,et al.  Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. , 1997, Science.

[25]  Yuan Zhang,et al.  Cooperative Transcriptional Activation by the Neurogenic Basic Helix-Loop-Helix Protein MASH1 and Members of the Myocyte Enhancer Factor-2 (MEF2) Family* , 1996, The Journal of Biological Chemistry.

[26]  B. Black,et al.  The Mouse MRF4 Promoter Is trans-Activated Directly and Indirectly by Muscle-specific Transcription Factors (*) , 1995, The Journal of Biological Chemistry.

[27]  P. Rigby,et al.  The regulation of myogenin gene expression during the embryonic development of the mouse. , 1993, Genes & development.

[28]  J. Rossant,et al.  Inducible expression of an hsp68-lacZ hybrid gene in transgenic mice. , 1989, Development.